ArticleHealth science reports2026
Trends in Age-Adjusted Cardiovascular Mortality Rates Among the Diabetic Population of the United States: 1999-2020, CDC WONDER Retrospective Study.
Article in Health science reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: This study examines trends in cardiovascular disease (CVD)-related mortality among individuals with diabetes mellitus (DM) in the United States from 1999 to 2020, focusing on age-adjusted mortality rates (AAMRs) across demographic and geographic subgroups. Methods: Using the CDC WONDER database, we analyzed death certificate data and calculated AAMRs standardized to the 2000 US population. Joinpoint regression was used to analyze annual percentage changes (APCs) in AAMRs by sex, race/ethnicity, and geographic region. Statistical significance was determined at Results: From 1999 to 2020, 1,854,384 deaths were attributed to circulatory disorders and DM, with an average AAMR of 25.1%. AAMRs showed a steady decline from 1999 (31.3/100,000) to 2014 (21.9/100,000), followed by an increase to 25.6/100,000 in 2020. Gender analysis revealed significant declines in AAMRs for both males and females, though the rate of decline slowed after 2012. Racial disparities were evident: non-Hispanic Whites and Asian or Pacific Islanders experienced reversals in mortality trends after earlier declines, while Hispanic or Latino groups exhibited a steep rise in AAMRs from 2016 to 2020 (APC = 10.84%). Geographic analysis highlighted considerable variation in mortality rates across states, with Oklahoma reporting the highest AAMR (59.3/100,000). Conclusions: While overall CVD mortality in individuals with DM has improved, recent increases in AAMRs and persistent demographic and geographic disparities underscore the need for targeted public health strategies. Addressing these disparities is critical to sustaining progress and improving outcomes for vulnerable populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.